Size matters: Ensuring donor pool sustainability and cell therapy supply chain success when scaling up and out

On-demand webinar

Contact our team to start building your solution

View this on-demand webinar to learn how to increase potential for long-term success in allogeneic and autologous programs. Discover the keys to enabling a smoother, faster transition to market and ultimately, access to more patients.

Our expert panelists will cover:

  • What to expect when transitioning from small trial sizes to large volumes, while also managing the disruptions inevitably associated with delivering human-based therapies
  • The importance of established global partnerships and strategies critical to successfully orchestrating scalable logistics in a highly variable environment
  • How donor pool size impacts scalable sourcing of quality starting material
  • How you can transform specialized and diverse knowledge of apheresis processes into highly productive site onboarding and training

Our panel includes:

  • Chris Learn, PhD, Senior Director, Therapeutic Science & Strategy, IQVIA
  • Ray Hornung, MBA, CEM, CBCP,Senior Manager, Logistics and Emergency Preparedness, Be The Match BioTherapies
  • Amit Agarwal, Managing Director, Life Sciences, Deloitte Consulting

Access the webinar